J1203 HCPCS Level II Code: Injection, cipaglucosidase alfa-atga, 5 mg

Drug products (NDC)

CMS ASP NDC-HCPCS Crosswalk · 2026 Q3

Medicare Part B payment limit (ASP + 6%): $96.30

71904-0200-01 — Pombiliti — Amicus Therapeutics US, LLC (size 1 × qty 1 (5 MG per billing unit))

From the CMS ASP NDC-HCPCS Crosswalk and Part B Payment Limit File. Payment limits apply per HCPCS billing code, not per package.

Contextual Map

Every relationship of J1203 in one view: hierarchy, official tabular instructions in both directions, clinical classification, risk adjustment, MS-DRG participation, index terms and change history — each edge carrying the CMS source it derives from.

Nearest codes (17)

• J1200 — Injection, diphenhydramine hcl, up to 50 mg[Sibling]
• J1201 — Injection, cetirizine hydrochloride, 0.5 mg[Sibling]
• J1202 — Miglustat, oral, 65 mg[Sibling]
• J1205 — Injection, chlorothiazide sodium, per 500 mg[Sibling]
• J1212 — Injection, dmso, dimethyl sulfoxide, 50%, 50 ml[Sibling]
• J1230 — Injection, methadone hcl, up to 10 mg[Sibling]
• J1240 — Injection, dimenhydrinate, up to 50 mg[Sibling]
• J1245 — Injection, dipyridamole, per 10 mg[Sibling]
• and 9 more

Change history

• April 1, 2024 — Added to the code set [Change history]

Nearest Codes in This Family

Official HCPCS Level II classifications closest to J1203 in its code family, with their registry titles.

• J1200 — Injection, diphenhydramine hcl, up to 50 mg
• J1201 — Injection, cetirizine hydrochloride, 0.5 mg
• J1202 — Miglustat, oral, 65 mg
• J1205 — Injection, chlorothiazide sodium, per 500 mg
• J1212 — Injection, dmso, dimethyl sulfoxide, 50%, 50 ml
• J1230 — Injection, methadone hcl, up to 10 mg
• J1240 — Injection, dimenhydrinate, up to 50 mg
• J1245 — Injection, dipyridamole, per 10 mg
• J1250 — Injection, dobutamine hydrochloride, per 250 mg
• J1260 — Injection, dolasetron mesylate, 10 mg